Advertisement
Screener

Actuate Therapeutics, Inc. (ACTU) Preferred Stock, Value, Issued

2.8 / 5 stars · 68/120 Roast Me

Actuate Therapeutics, Inc. Preferred Stock, Value, Issued

Actuate Therapeutics, Inc. (ACTU) had Preferred Stock, Value, Issued of $0 as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:PreferredStockValue · last filed 2026-08-14

  • 2026-06-30: Preferred Stock, Value, Issued $0.00.
  • 2026-03-31: Preferred Stock, Value, Issued $0.00.
  • 2025-12-31: Preferred Stock, Value, Issued $0.00.
  • 2025-09-30: Preferred Stock, Value, Issued $0.00.
Period endPreferred Stock, Value, Issued
2026-06-30$0.00
10-Q · filed 2026-08-14
2026-03-31$0.00
10-Q · filed 2026-05-14
2025-12-31$0.00
10-Q · filed 2026-08-14
2025-09-30$0.00
10-Q · filed 2025-11-13
2025-06-30$0.00
10-Q · filed 2025-08-14
2025-03-31$0.00
10-Q · filed 2025-05-15
2024-12-31$0.00
10-K · filed 2026-03-26
2024-09-30$0.00
10-Q · filed 2024-11-13
2023-12-31$0.00
10-K · filed 2025-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B